IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.274
-0.010 (-3.66%)
At close: Apr 28, 2026, 4:00 PM EDT
0.285
+0.011 (4.13%)
After-hours: Apr 28, 2026, 7:47 PM EDT
IceCure Medical Employees
As of December 31, 2025, IceCure Medical had 69 total employees, including 67 full-time and 2 part-time employees. The number of employees increased by 3 or 4.55% compared to the previous year.
Employees
69
Change (1Y)
3
Growth (1Y)
4.55%
Revenue / Employee
$48,971
Profits / Employee
-$218,217
Market Cap
22.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 713 |
| TELA Bio | 209 |
| Myomo | 195 |
| Cytosorbents | 129 |
| IRIDEX | 93 |
| Lifeward | 81 |
| Adagio Medical Holdings | 80 |
| VolitionRx | 75 |
ICCM News
- 7 days ago - IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 - PRNewsWire
- 4 weeks ago - IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement - PRNewsWire
- 4 weeks ago - IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates - PRNewsWire
- 5 weeks ago - IceCure Appoints Meir Peleg as Chief Financial Officer - PRNewsWire
- 6 weeks ago - IceCure Medical Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - IceCure Reports 2025 Full Year Financial & Operational Results - PRNewsWire
- 6 weeks ago - U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer - PRNewsWire
- 7 weeks ago - IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - PRNewsWire